Mahmod group
Our expertise is in clinical trials, whereby we aim to discover novel treatments for improving the health of patients with cardiac diseases. We use cardiovascular magnetic resonance imaging (CMR) and spectroscopy techniques to improve our understanding of myocardial metabolism and function, and for early detection of cardiac abnormalities in cardiomyopathy, heart failure, valve disease and diabetes. We use cardiopulmonary exercise test to understand cardiovascular exercise physiology, by studying how oxygen and other nutrients are used by the heart during exercise. We work closely with multidisciplinary research teams including MR physicists, biomedical engineers and other cardiac imaging experts in the UK and elsewhere in the world.
Our main current studies are
The EMPA-Vision trial
Ox-FAST study
collaborators (UK)
- Dr Pablo Lamata, King’s College London, UK
- Dr Sanjay Prasad, Royal Brompton and Harefield NHS Trust, UK
- Prof Mary Sheppard, St George’s, University of London, UK
- Prof Jules Griffin, University of Cambridge, UK
- Prof Vicente Grau, University of Oxford, UK
collaborators (outside the UK)
- Prof Alistair Young, University of Auckland, New Zealand
- Dr James White, University of Calgary, Canada
- Dr Ntobeko Ntusi, Groote Schuur Hospital, Capetown, South Africa
- Dr Raymond Kwong, Havard Medical School, USA
- Prof Jean-Luc Balligand, Université catholique de Louvain, Belgium
- Dr Christopher Kramer, University of Virginia, USA